E.U.R.L. PHARMACIE LAMBERT

E.U.R.L. PHARMACIE LAMBERT

SIREN 484892591

Active

What the register says about E.U.R.L. PHARMACIE LAMBERT

E.U.R.L. PHARMACIE LAMBERT is registered under SIREN number 484892591. Its registered office is located at 6 Avenue Bonaparte, 51430 Tinqueux. The company was founded on 04/11/2005. It declares that it operates in the Commerce de détail de produits pharmaceutiques en magasin spécialisé sector. It is currently listed as active in the national business register.

BODACC has published 23 notices concerning it, the most recent dated 11/06/2026. An account filing makes public the annual accounts submitted to the court registry: it confirms that accounting records exist and have been filed, nothing more. It says nothing about revenue, profit, or the commercial health of the company. A modification signals a declared change: management, registered office, activity, or share capital.

Identity : E.U.R.L. PHARMACIE LAMBERT

E.U.R.L. PHARMACIE LAMBERT

SIREN
484892591
Head office SIRET
48489259100013
Legal form
5485
NAF code
47.73Z · Commerce de détail de produits pharmaceutiques en magasin spécialisé
Address
6 Avenue Bonaparte, 51430 Tinqueux
Creation date
11/04/2005
Category
PME
Status
Active
VAT
FR19484892591
Filing
06/11/2026
Closing
12/31/2025

Recent notices (23)

All legal notices

Web presence : E.U.R.L. PHARMACIE LAMBERT

The company's official website, its networks and online contact details.

Recent notices : E.U.R.L. PHARMACIE LAMBERT

The BODACC notices published for this company.

Relations : E.U.R.L. PHARMACIE LAMBERT

The relationship graph: linked notices, people and companies.

Public contracts : E.U.R.L. PHARMACIE LAMBERT

The public contracts won by the company.

No won public contract found for this company

FAQ & filings : E.U.R.L. PHARMACIE LAMBERT

Frequently asked questions and the company's filing history.

Frequently asked questions : E.U.R.L. PHARMACIE LAMBERT

Deposit filing history

10 dépôts de comptes enregistrés au BODACC — dernier exercice clos le 12/31/2025.